U.S. Markets closed

United Therapeutics Corporation (UTHR)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
131.59-0.11 (-0.08%)
At close: 4:00PM EDT
People also watch
ALXNBMRNVRTXMDCOMYGN
Full screen
Previous Close131.70
Open131.86
Bid111.17 x 100
Ask167.89 x 100
Day's Range130.76 - 132.87
52 Week Range97.52 - 169.89
Volume1,195,642
Avg. Volume603,635
Market Cap5.93B
Beta1.33
PE Ratio (TTM)9.24
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Barrons.com8 hours ago

    [$$] Biotech Blazes Higher

    It takes just one match to start a fire, but last week the biotech sector got two. Investors should take care not to get burned. The sector got a boost not only from the Senate’s health-care plan, which made nary a mention of the high cost of drugs, but also from a draft of an executive order by President Donald Trump, which appeared to remove the threat of imminent action to rein in prices.

  • GuruFocus.com4 days ago

    Argan and Sturm Ruger Show High Profit and Low Debt

    Five recommendations

  • American City Business Journals10 days ago

    Silver Spring tissue regeneration company raises $12 million

    HighCape Partners, a New York equity fund and majority owner of Aziyo, led the funding round for the local company, which creates customized human tissue products for use in orthopedic, spinal, sports medicine and dermal surgeries. Several of its products are allografts — or tissue grafts from donors — for bone repair, ligament replacement and skin grafts.